High-dose chemotherapy in high-risk breast cancer

Comment

L A Price. Lancet. 1998.

. 1998 Nov 7;352(9139):1551-2.

doi: 10.1016/s0140-6736(05)60359-5.

No abstract available

Comment on

Discouraging news for high-dose chemotherapy in high-risk breast cancer.
Pusztai L, Hortobagyi GN. Pusztai L, et al. Lancet. 1998 Aug 15;352(9127):501-2. doi: 10.1016/S0140-6736(05)79310-7. Lancet. 1998. PMID: 9716049 No abstract available.
Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvement.
Rodenhuis S, Richel DJ, van der Wall E, Schornagel JH, Baars JW, Koning CC, Peterse JL, Borger JH, Nooijen WJ, Bakx R, Dalesio O, Rutgers E. Rodenhuis S, et al. Lancet. 1998 Aug 15;352(9127):515-21. doi: 10.1016/S0140-6736(98)01350-6. Lancet. 1998. PMID: 9716055 Clinical Trial.